Even if your fat started out looking healthier or less healthy on the scan, the drug still made it denser — the effect doesn’t depend on where you started.
Scientific Claim
In people living with HIV (PWH) with central adiposity, the effect of tesamorelin on fat density is independent of baseline fat density, as the increase persisted after adjusting for baseline Hounsfield Unit values.
Original Statement
“The tesamorelin effects persisted after controlling for baseline VAT or SAT HU and area...”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim accurately reflects the statistical adjustment performed and does not overreach beyond the data. Language is precise and evidence-based.
Evidence from Studies
Supporting (1)
Tesamorelin improves fat quality independent of changes in fat quantity
Even if someone started with very low-quality fat, tesamorelin still made their fat healthier and denser — and this improvement wasn’t just because they lost fat, but because the drug itself improved fat quality.